259 related articles for article (PubMed ID: 8171012)
1. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
Ye X; McCarrick J; Jewett L; Knowles BB
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
[TBL] [Abstract][Full Text] [Related]
2. Early immunization induces persistent tumor-infiltrating CD8+ T cells against an immunodominant epitope and promotes lifelong control of pancreatic tumor progression in SV40 tumor antigen transgenic mice.
Otahal P; Schell TD; Hutchinson SC; Knowles BB; Tevethia SS
J Immunol; 2006 Sep; 177(5):3089-99. PubMed ID: 16920946
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of MHC class I antigen in insulinoma cells controlled by the R1 element of the H-2 enhancer.
Ye X; Kralli A; Ge R; Ricciardi RP; Knowles BB
Oncogene; 1994 Apr; 9(4):1195-204. PubMed ID: 8134122
[TBL] [Abstract][Full Text] [Related]
4. Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.
Faas SJ; Pan S; Pinkert CA; Brinster RL; Knowles BB
J Exp Med; 1987 Feb; 165(2):417-27. PubMed ID: 3029269
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance.
Smith KM; Olson DC; Hirose R; Hanahan D
Int Immunol; 1997 Sep; 9(9):1355-65. PubMed ID: 9310839
[TBL] [Abstract][Full Text] [Related]
6. Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy.
Speiser DE; Miranda R; Zakarian A; Bachmann MF; McKall-Faienza K; Odermatt B; Hanahan D; Zinkernagel RM; Ohashi PS
J Exp Med; 1997 Aug; 186(5):645-53. PubMed ID: 9271580
[TBL] [Abstract][Full Text] [Related]
7. Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas.
Marton I; Johnson SE; Damjanov I; Currier KS; Sundberg JP; Knowles BB
Transgenic Res; 2000 Apr; 9(2):115-25. PubMed ID: 10951695
[TBL] [Abstract][Full Text] [Related]
8. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.
Mylin LM; Schell TD; Roberts D; Epler M; Boesteanu A; Collins EJ; Frelinger JA; Joyce S; Tevethia SS
J Virol; 2000 Aug; 74(15):6922-34. PubMed ID: 10888631
[TBL] [Abstract][Full Text] [Related]
10. T cells are responsive to the simian virus 40 large tumor antigen transgenically expressed in pancreatic islets.
Geiger T; Soldevila G; Flavell RA
J Immunol; 1993 Dec; 151(12):7030-7. PubMed ID: 8258707
[TBL] [Abstract][Full Text] [Related]
11. SV40 T antigen transgenic mice: cytotoxic T lymphocytes as a selective force in tumor progression.
Knowles BB; Faas S; Juretic A; Fox N; Crooke R; Hanahan D; Solter D; Jewett L
Basic Life Sci; 1991; 57():111-24; discussion 125. PubMed ID: 1726037
[No Abstract] [Full Text] [Related]
12. Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.
Schell TD; Mylin LM; Georgoff I; Teresky AK; Levine AJ; Tevethia SS
J Virol; 1999 Jul; 73(7):5981-93. PubMed ID: 10364350
[TBL] [Abstract][Full Text] [Related]
13. Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
Neeley YC; Arredouani MS; Hollenbeck B; Eng MH; Rubin MA; Sanda MG
Prostate; 2008 May; 68(7):715-27. PubMed ID: 18302222
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes.
Ganss R; Hanahan D
Cancer Res; 1998 Oct; 58(20):4673-81. PubMed ID: 9788621
[TBL] [Abstract][Full Text] [Related]
15. T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus.
Jolicoeur C; Hanahan D; Smith KM
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6707-11. PubMed ID: 8022837
[TBL] [Abstract][Full Text] [Related]
16. Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice.
Nogues N; Magnan E; De Grandis P; Butz M; Kineman RD; Kopchick JJ; Frohman LA
Mol Cell Endocrinol; 1998 Feb; 137(2):161-8. PubMed ID: 9605518
[TBL] [Abstract][Full Text] [Related]
17. Limited capacity for tolerization of CD4+ T cells specific for a pancreatic beta cell neo-antigen.
Förster I; Hirose R; Arbeit JM; Clausen BE; Hanahan D
Immunity; 1995 Jun; 2(6):573-85. PubMed ID: 7796292
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD40 conditioning enhances the T(CD8) response to a highly tolerogenic epitope and subsequent immunotherapy of simian virus 40 T antigen-induced pancreatic tumors.
Otahal P; Knowles BB; Tevethia SS; Schell TD
J Immunol; 2007 Nov; 179(10):6686-95. PubMed ID: 17982058
[TBL] [Abstract][Full Text] [Related]
19. SV40 T antigen acts as a minor histocompatibility antigen of SV40 T antigen tolerant transgenic mice.
Juretic A; Knowles BB
Immunogenetics; 1989; 29(6):366-70. PubMed ID: 2786497
[TBL] [Abstract][Full Text] [Related]
20. Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene.
Teitz T; Chang JC; Kitamura M; Yen TS; Kan YW
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2910-4. PubMed ID: 7681991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
